How Is Lyme Disease Diagnosed? A Three-Step Framework for Primary Care

Recognize the clinical syndrome
Understand disease stage and testing limitations
Use clinical judgment alongside laboratory findings

Diagnosing Lyme disease is not always straightforward. Early symptoms can resemble a viral illness, laboratory testing may be be negative during the first weeks of infection, and later disease can affect the joints, nervous system, heart, or cognitive function. Although laboratory testing can support the diagnosis, Lyme disease remains a clinical diagnosis based on symptoms, exposure history, physical examination, and appropriate use of testing.

For years, Lyme disease has presented primary care clinicians with diagnostic challenges. The symptoms can be vague or migratory. Testing has important limitations—particularly during early infection. As a result, some patients are reassured that everything is normal even as their symptoms continue to evolve.

Over nearly four decades of treating patients with Lyme disease, I’ve found that a simple three-step framework helps organize the diagnostic process. This approach emphasizes clinical judgment, recognition of symptom patterns, thoughtful use of laboratory testing, and collaboration when cases become more complex.

How Is Lyme Disease Diagnosed?

Diagnosing Lyme disease begins with the patient’s history and clinical presentation rather than laboratory testing alone. Physicians should consider recent tick exposure, outdoor activities, travel to endemic areas, seasonal timing, physical examination findings, and the evolution of symptoms over time.

If an erythema migrans (EM) rash is present, Lyme disease can be diagnosed clinically without waiting for laboratory confirmation. In patients without the classic rash, laboratory testing may support the diagnosis, but results should always be interpreted in the context of the overall clinical picture.

Because early Lyme disease is often the easiest stage to treat, recognizing the clinical syndrome before laboratory confirmation may improve outcomes.

Step 1: Recognize the Clinical Syndrome

The first step is determining whether the patient’s symptoms fit the clinical profile of Lyme disease.

Early signs may include:

1. Erythema migrans (EM) rash
2. Fever, chills, fatigue
3. Headache and muscle aches

Later or persistent signs may include:

1. Migratory joint pain, especially involving the knees
2. Facial palsy
3. Neuropathic pain
4. Cognitive dysfunction (“brain fog”)
5. Postural Orthostatic Tachycardia Syndrome (POTS)
6. Mood changes and sleep disturbance

Lyme disease remains a clinical diagnosis, particularly during the early stages of infection. Patients with a characteristic erythema migrans rash should be diagnosed clinically without waiting for laboratory confirmation, while patients without a rash require integration of exposure history, symptom pattern, physical findings, and appropriately timed testing.^1-3

If an EM rash is present, treatment should begin promptly without waiting for laboratory confirmation. If the rash is absent but the exposure history and symptom pattern strongly suggest Lyme disease, laboratory testing may provide supportive evidence but should not replace clinical judgment.

Always obtain a careful exposure history, including tick activity, geographic risk, outdoor activities, seasonality, and any unexplained flu-like illness that may have represented early Lyme disease.

Step 2: Determine the Stage of Lyme Disease

Once Lyme disease is suspected, determine how far the illness has progressed and whether multiple organ systems are involved. Staging helps guide both diagnostic evaluation and treatment decisions.

Clinical stages may include:

1. Localized disease: EM rash with flu-like symptoms.
2. Disseminated disease: Joint pain, Bell’s palsy, cardiac manifestations, or autonomic symptoms such as POTS.
3. Persistent manifestations: Fatigue, cognitive dysfunction, neuropathy, and autonomic instability that continue after infection has become more widespread.

Ask whether the patient received previous antibiotic treatment, how early treatment began, and whether symptoms improved, persisted, or later returned. Delayed diagnosis or incomplete treatment may contribute to a more complicated clinical course, although the reasons persistent symptoms develop remain an area of active research.

Also determine whether evaluation for Babesia, Bartonella, Ehrlichia, or Anaplasma has been considered. These tick-borne infections can occur alongside Lyme disease and may contribute to persistent fever, neurologic symptoms, fatigue, or delayed recovery.

Step 3: Understand Lyme Disease Testing—and Its Limitations

Laboratory testing can support a Lyme disease diagnosis, but it should be ordered and interpreted in the context of the patient’s symptoms, exposure risk, physical findings, and stage of illness.

Current CDC recommendations include either the standard two-tier testing (STTT) algorithm, consisting of an enzyme immunoassay followed by an immunoblot, or the modified two-tier testing (MTTT) algorithm, which uses two sequential enzyme immunoassays. Both approaches improve diagnostic accuracy when used at the appropriate stage of illness, but neither replaces careful clinical assessment.^1-4

Many patients searching for a “Lyme disease blood test” are surprised to learn that laboratory testing is only one part of the diagnostic process.

Important limitations include:

1. Antibodies may not yet be detectable during the first days or weeks of infection.
2. Early antibiotic treatment may reduce or delay development of a measurable antibody response in some patients.
3. A positive antibody test may reflect previous exposure and does not, by itself, establish active illness.
4. A negative test should not automatically overrule a convincing clinical presentation, particularly during early infection.

If an erythema migrans rash is present, laboratory testing is not required to make the diagnosis. In patients without an EM rash, testing may help support the diagnosis, but results should always be interpreted alongside the patient’s history, examination findings, and timing of illness.

Serologic testing generally becomes more sensitive several weeks after symptom onset as the antibody response develops. When an initial test is negative but early Lyme disease remains a concern, repeat testing may be appropriate if symptoms persist and clinical suspicion remains high.^1,2,4

Additional laboratory studies may help evaluate the patient’s general condition or identify alternative explanations, but they do not independently diagnose Lyme disease.

Depending on the presentation, clinicians may consider:

1. CBC and comprehensive metabolic panel
2. Liver enzymes and inflammatory markers
3. Thyroid testing
4. Vitamin B12, folate, iron, or vitamin D levels when clinically appropriate
5. Testing for other tick-borne infections based on exposure history, geography, and symptoms

A normal CBC does not rule out Lyme disease. Likewise, abnormalities such as anemia, thrombocytopenia, elevated liver enzymes, or changes in white blood cell counts may suggest another tick-borne infection but are not specific enough to establish a diagnosis on their own.

Testing for co-infections should also be selective. Babesia, Anaplasma, Ehrlichia, and Bartonella have different clinical presentations, laboratory findings, and geographic distributions. Testing should be guided by the patient’s symptoms and epidemiologic risk rather than ordered routinely in every patient with suspected Lyme disease.

When neurologic, cardiac, rheumatologic, autonomic, or psychiatric symptoms make the presentation more complex, consultation can be valuable. Collaboration with a clinician experienced in Lyme disease and other tick-borne infections may help clarify the differential diagnosis, determine whether additional testing is warranted, and guide individualized management.

Referral is not a sign of uncertainty. It reflects a commitment to thorough, patient-centered care when the clinical picture extends beyond a straightforward early infection.

What Long COVID Has Taught Us About Post-Infectious Illness

Although Lyme disease and Long COVID are distinct conditions, both demonstrate that recovery after an infection is not always immediate or predictable. Some patients continue to experience symptoms affecting multiple organ systems even when routine laboratory testing does not fully explain their impairment.

For patients whose symptoms persist after treatment, clinicians should reconsider the original diagnosis, review treatment history, evaluate for possible co-infections or complications, and investigate alternative medical conditions when appropriate. The goal is not to attribute every symptom to Lyme disease, but to continue thoughtful clinical evaluation when recovery does not follow the expected course.

Frequently Asked Questions

How is Lyme disease diagnosed?

Lyme disease is diagnosed by combining the patient’s symptoms, exposure history, physical examination, disease stage, and laboratory testing when appropriate. An erythema migrans rash can establish the diagnosis without a blood test.

Can Lyme disease be diagnosed without a bull’s-eye rash?

Yes. Many patients do not notice a rash, and not every erythema migrans rash has a classic bull’s-eye appearance. When a rash is absent, clinicians rely more heavily on exposure history, symptom evolution, examination findings, and appropriately timed laboratory testing.

Can a Lyme disease blood test be negative?

Yes. Blood tests may be negative during the first days or weeks of infection because antibodies have not yet reached detectable levels. Early antibiotic treatment may also reduce or delay antibody production in some patients. Test results should always be interpreted in the clinical context.

Does a CBC diagnose Lyme disease?

No. A CBC cannot confirm or exclude Lyme disease. It may identify abnormalities that suggest another diagnosis or a tick-borne co-infection, but many patients with Lyme disease have a normal CBC.

What is the most accurate test for Lyme disease?

No single laboratory test is accurate in every stage of Lyme disease. Current CDC-recommended standard and modified two-tier testing perform best after the immune system has produced detectable antibodies. Test accuracy depends on the timing of infection, clinical presentation, and appropriate interpretation.

Should treatment wait for Lyme disease test results?

Not when a patient has a clinically compatible erythema migrans rash. In other situations, the decision to begin treatment before results are available depends on the strength of the clinical suspicion, illness severity, disease stage, and competing diagnoses.

Clinical Takeaway

Diagnosing Lyme disease requires more than interpreting laboratory test results. It begins with recognizing compatible symptoms, understanding the patient’s exposure history, appreciating the strengths and limitations of current testing, and reassessing the diagnosis as new clinical information becomes available.

Most patients can be evaluated successfully using a structured clinical approach that combines history, physical examination, appropriate laboratory testing, and careful follow-up. When presentations become unusually complex, consultation with clinicians experienced in Lyme disease and other tick-borne diseases may help clarify the diagnosis, guide additional evaluation, and refine treatment decisions.

Early recognition, sound clinical judgment, and ongoing reassessment remain the foundations of accurate Lyme disease diagnosis.

Related Articles

Explore additional resources on Lyme disease diagnosis, testing, treatment, and recovery:

How Accurate Are Lyme Disease Tests?
Why Lyme Disease Tests Can Be Negative Early
Lyme Disease Symptoms Guide
Lyme Disease Treatment
Lyme Disease Misdiagnosis
Tick-Borne Coinfections
Recovery From Lyme Disease

References

1. Centers for Disease Control and Prevention. Clinical Testing and Diagnosis for Lyme Disease.
2. Centers for Disease Control and Prevention. Pretest Probability and Laboratory Testing for Lyme Disease.
3. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis. 2021;72(1):e1-e48.
4. Branda JA, Lantos PM, Strle F, et al. Advances in Serodiagnostic Testing for Lyme Disease Are at Hand. Clin Infect Dis. 2021;72(2):271-277.
5. Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis. JAMA. 2016;315(16):1767-1777.
6. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis. Clin Infect Dis. 2006;43(9):1089-1134.
7. Cameron DJ, Johnson LB, Maloney EL. Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes, and Persistent Disease. Expert Rev Anti Infect Ther. 2014;12(9):1103-1135.
8. Branda JA, Lantos PM. Advances in Serodiagnostic Testing for Lyme Disease Are at Hand. Clin Infect Dis. 2021;72(2):271-277.
9. Centers for Disease Control and Prevention. Lyme Disease: Information for Healthcare Providers.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention